
|Videos|October 18, 2020
What keeps you up at night in ophthalmology: Part II
Author(s)Alex Delaney-Gesing
Pharmaceutical representatives share what keeps them up at night within the ophthalmic space.
Advertisement
In this second video installment, pharmaceutical representatives share what keeps them up at night within the ophthalmic and glaucoma space while attending the 2020
Featured: Chris Adams, Diopter Corp (CEO); Daria Lemann-Blumenthal, BELKIN Laser Ltd (CEO); Victor Chan, MB, MS, director of U.S. Surgical Device Commercial Marketing (Santen, Inc); Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline (Allergan).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: Non-invasive electrical stimulation therapy for intermediate dry AMD: improved retinal health and visual acuity
2
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
3
Subramanian, MD: anti-VEGF linked to kidney function decline
4
Retina Society 2026: Could statins reduce PVR risk after RD repair?
5











